Global Porokeratosis Treatment Market Driven by Increasing Awareness and Advancements in Therapies: Expected to Grow at 7% CAGR Between 2023 and 2031 - ResearchAndMarkets.com
Global Porokeratosis Treatment Market Driven by Increasing Awareness and Advancements in Therapies: Expected to Grow at 7% CAGR Between 2023 and 2031 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Porokeratosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031" report has been added to ResearchAndMarkets.com's offering.
The global market for porokeratosis treatment is projected to register a significant growth, expanding at a CAGR of 7% during the forecast period of 2023 to 2031.
The driving forces behind this robust growth include increased renal transplant cases, improved reimbursement policies, rising research funding, and fierce competition among market participants.
Key factors propelling the growth include:
- Rising prevalence of porokeratosis, a rare skin condition whose incidence has surged due to increased UV radiation exposure and immunosuppressive drug usage.
- Increased awareness among healthcare professionals and patients, driving demand for effective treatments.
- Technological advancements in dermatology and development of new, more effective therapies, including topical and systemic therapies, photodynamic and laser therapies.
- Growing prevalence of Disseminated Superficial Actinic Porokeratosis (DSAP) – the most common form of porokeratosis.
- Increasing demand for aesthetic products, with consumers considering porokeratosis treatment as a necessary tool for healthier lifestyle.
- Laser therapy is becoming the fastest-growing treatment method for porokeratosis owing to its risk-free nature and lack of associated downtime.
- Hospitals are expected to remain the dominant end-users due to comprehensive diagnosis and treatment services.
- North America is projected to dominate the market due to the rising prevalence of DSAP and increased number of renal transplants. However, Europe and Asia are also contributing significantly to market growth, thanks to rising incidences and healthcare infrastructure expansion.
The market, however, faces potential roadblocks from side effects of treatments, high treatment costs, and lack of awareness about skin treatments.
In a bid to stay competitive, key market players are actively investing in R&D for more effective and superior treatments for porokeratosis, especially in developing countries where aesthetic spending is still relatively low.
The report segments the global porokeratosis treatment market as follows:
Market Segmentation
- Type: Disseminated Superficial Actinic Porokeratosis, Disseminated Superficial Porokeratosis, Surface Treatment Porokeratosis of Mibelli, Injectable Linear Porokeratosis, Eruptive Disseminated Porokeratosis, Porokeratosis Plantaris Palmaris et Disseminata, Punctate Porokeratosis, Porokeratosis Ptychotropica, Penoscrotal Porokeratosis, Follicular Porokeratosis
- Diagnosis: Biopsy, Differential Diagnosis, Squamous Cell Carcinoma, Lichenoid Keratosis, Epidermal Nevus, Others
- Treatment: Topical Therapies, Combination Therapy, Systemic Therapy, Physical Interventions, Laser Therapy
- End-user: Hospitals, Clinics, Pharmacies and Drug Stores, Diagnostic Centers, Research and Academic Institutes, Others
The report answers crucial questions about the market, such as:
- What are the key environmental factors impacting the market growth?
- What are the key investment pockets currently and during the forecast period?
- Which market segment holds a larger market share and why?
- What are the market trends and dynamics in emerging markets?
- Who are the key competitors and what are their strategies?
Companies Mentioned
- Coherent Inc.
- Alma Lasers
- Almirall
- Allergan
- Pfizer
- Lumenis
- Coty Inc.
- Cutera
- Bioness Inc.
- Biogen
- PhotoMedex Inc.
- Valeant Pharmaceuticals
- Hologic Inc.
- IPG Photonics Corporation
- IRIDEX Corp.
For more information about this report visit https://www.researchandmarkets.com/r/65b75o
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
